Content Video
Creating a control strategy and exporting an audit-ready report
Summary
Control strategy work slows down when decisions sit across spreadsheets, slide decks, and email threads. When one change takes days to trace, the system is creating the drag.
Valgenesis iCMC structures process knowledge, connects QTPP, CQAs, CPPs, and risk assessments, and keeps decisions linked across development, tech transfer, and manufacturing.
Key Takeaways
-
A control strategy needs connected product and process understanding across the lifecycle.
-
Manual work makes teams collect files, reconcile versions, chase approvals, and rebuild reports.
-
Valgenesis iCMC helps teams manage change history, link decisions, and export an audit-ready report.
Who is this for
-
CMC development leaders
-
Process development scientists and engineers
-
Technology transfer leads
-
Quality assurance teams
-
Regulatory affairs professionals
-
Manufacturing science and technology teams
-
Validation and risk management teams
Relevant Entities and Links
ICH Quality Guidelines are relevant because the content refers to product and process understanding, lifecycle control, and structured quality practices.
ICH Q8(R2) Pharmaceutical Development is relevant to QTPP, CQAs, process development, and control strategy concepts.
ICH Q9(R1) Quality Risk Management is relevant to risk assessments and risk-based decisions in control strategy work.
ICH Q10 Pharmaceutical Quality System is relevant to lifecycle management of product and process knowledge.
FDA Process Validation: General Principles and Practices is relevant to process understanding from design through commercial manufacturing.
FDA Part 11: Electronic Records; Electronic Signatures is relevant to electronic records and signatures used in regulated, audit-ready documentation.